CVE-2024-2275
Bdtask G-Prescription Gynaecology & OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting
Vexday Risk Score
8Low
SSVC decision (CISA)
Track
No exploitation signal → monitor
CVSS 2.4EPSS 0.5%KEV nãoPoC —Nuclei —Metasploit —Patch —
Lifecycle
08 Mar 2024Published on NVD
Recommendation: Monitor — no exploitation signal at the moment.
A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N
Affected products
Bdtask · G-Prescription Gynaecology & OBS Consultation SoftwareWant to know if your infrastructure is exposed to this?
Talk to TrueHacking →